CD8A and malaria: The induction of higher-level protective efficacy with vectors is a priority for malaria vaccine development as only one malaria vaccine has induced repeatable efficacy in field trials20, 21; this protective efficacy is associated with high titres of antibodies against sporozoites but no CD8+ T cell induction.